Home/Filings/4/0001214659-24-004309
4//SEC Filing

BRAENDER LORI J 4

Accession 0001214659-24-004309

CIK 0001398733other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 10:36 AM ET

Size

7.3 KB

Accession

0001214659-24-004309

Insider Transaction Report

Form 4
Period: 2024-03-07
BRAENDER LORI J
Chief Legal Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2024-03-07+67,50067,500 total
    Exercise: $5.68Exp: 2034-03-07Common Stock (67,500 underlying)
  • Award

    Common Stock

    2024-03-07+135,000323,761 total
Footnotes (2)
  • [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
  • [F2]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001752955

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 10:36 AM ET
Size
7.3 KB